Related Experiment Videos

Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding

Joseph J Y Sung1, Francis K L Chan, Minhu Chen

  • 1Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong. joesung@cuhk.edu.hk

Gut
|April 8, 2011
PubMed

Insights

Asian experts recommend the Blatchford score for assessing upper gastrointestinal bleeding (UGIB) risk and guiding treatment. Early discharge for low-risk patients and specific proton pump inhibitor (PPI) strategies are advised.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Practice Guidelines

Background:

  • Upper gastrointestinal bleeding (UGIB), particularly peptic ulcer bleeding, is a significant cause of mortality and hospitalization globally.
  • Regional variations in Helicobacter pylori infection, drug metabolism, and socioeconomic factors necessitate localized guidelines for UGIB management in Asia.
  • Existing international consensus requires re-evaluation with data specific to Asian populations.

Framework:

  • The working group, comprising experts from 12 Asian countries, developed recommendations for non-variceal UGIB.
  • Emphasis was placed on utilizing data generated from the Asian region to tailor clinical practice.
  • Key recommendations focus on risk stratification, endoscopic intervention, and pharmacological management.

Implementation:

  • The Blatchford score is recommended for selecting patients needing endoscopic intervention, facilitating early discharge for low-risk individuals.
  • Patient comorbid conditions must be integrated into the risk assessment process.
  • Proton pump inhibitors (PPIs) are crucial: pre-endoscopy PPIs as a stop-gap, endoscopic treatment with PPIs for adherent clots, and high-dose IV/oral PPIs are recommended, while low-dose IV PPIs should be avoided.

Implications:

  • Guidelines support the use of COX-2 selective non-steroidal anti-inflammatory drugs with PPIs for very high-risk UGIB patients.
  • Aspirin resumption post-stabilization is advised; clopidogrel alone offers no additional safety over aspirin plus PPI.
  • Prophylactic PPI use is recommended when dual antiplatelet agents are administered to mitigate gastrointestinal adverse events.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...